Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Combivir (AZT/3TC)

The Basics | News | Research

See also: Medication Side Effects | Drug Interactions

Show Archived (Historical) Articles

Brand Name:	Combivir
Generic Name:	Zidovudine and lamivudine, AZT and 3TC
Adult Single Dose:	One tablet containing 300 mg AZT and 150 mg 3TC (twice a day)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

The Basics

An Overview of Combivir (AZT/3TC) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Combivir (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Combivir (Zidovudine + Lamivudine) (November 7, 2007)
To read PDF, click here
From AIDS InfoNet
Combivir (AZT + Epivir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Patient Information About Combivir (AZT/3TC) (PDF) (March 2007)
From GlaxoSmithKline
Combivir (AZT/3TC) (October 19, 2006)
From AIDS Treatment Data Network

News

Ziagen Pills Found in Fake Combivir Packaging (March 29, 2007)
To read PDF, click here
From GlaxoSmithKline

Research

Switching From Zidovudine/Lamivudine to Tenofovir/Emtricitabine: Results of an Uncontrolled Cohort (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
Zidovudine/Lamivudine Inferior as First-Line NRTI Backbone (August 15, 2006)
In XVI International AIDS Conference
Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.